medigraphic.com
ISSN 1405-1699 (Print)
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

2014, Number 1

<< Back

Alerg Asma Inmunol Pediatr 2014; 23 (1)

Kawasaki disease: One of the most common primary vasculitis in childhood

Mendieta-Zerón S, Zepeda-Ortega B, León-Ramírez CG

Language: Spanish
References: 25
Page: 27-32
PDF size: 213.50 Kb.


ABSTRACT

Kawasaki disease (KD) represents one of the most frequent vasculitis during the childhood which importance takes root because it affects the coronary arteries, turning this way into the first reason of acquired cardiopathy in children. The aim of this review article is to provide a tool updated for the best understanding of the disease and to provide the recent advances in the understanding of its physiopathology, as well as the long-term follow-up and treatment.


REFERENCES

  1. Newburger JW et al. Diagnosis, treatment, and long-term management of Kawasaki disease. Circulation 2004; 110: 2747-2771.

  2. Kawasaki T. Febricula oculo-oro cutaneous acrodesquimatous, syndrome with or without acute non-supurative cervical lymphadenitis in infancy and childhood: clinical observations of 50 cases. Allergy 1967; 16: 178-222.

  3. Rodríguez SR. Síndrome linfomucocutáneo. Bol Med Hosp Infant Méx 1977; 34: 53-7.

  4. Holman RC, Curns AT, Belay ED, Steiner CA, Schonberger LB. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics 2003; 112: 495-501.

  5. Chang RK. The incidence of Kawasaki disease in the United States did not increase between 1988 and 1997. Pediatr 2003; 111: 1124-1125.

  6. Burns JC, Glode MP, Clarke SH, Wiggins J Jr, Hathaway WE. Coagulopathy and platelet activation in Kawasaki syndrome: identification of patients at high risk for development of artery aneurysms. J Pediatr 1984; 105: 206-211.

  7. Burns JC, Shike H, Gordon JB, Malhotra A, Schoenwetter M, Kawasaki T. Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol 1996; 28: 253-257.

  8. Leung DY, Giorno RC, Kazemi LV, Flynn PA, Busse JB. Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome. J Immunol 1995; 155: 5018–5021.

  9. Leung DY. Superantigens related to Kawasaki syndrome. Springer Semin Immunopathol 1996; 17: 385-396.

  10. Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, Leung DY. Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci U S A 1992; 89: 4066-4070.

  11. Yamashiro Y, Nagata S, Oguchi S, Shimizu T. Selective increase of V beta 2+ T cells in the small intestinal mucosa in Kawasaki disease. Pediatr Res 1996; 39: 264-266.

  12. Rowley AH, Eckerley CA, Jack HM, Shulman ST, Baker SC. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol 1997; 159(12): 5946-5955.

  13. Rowley AH, Shulman ST, Spike BT, Mask CA, Baker SC. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol 2001; 166: 1334-1343.

  14. Rowley AH, Shulman ST, Mask CA, Finn LS, Terai M, Baker SC, Galliani CA, Takahashi K, Naoe S, Kalelkar MB, et al. IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J Infect Dis 2000; 182: 1183-1191.

  15. Brown TJ, Crawford SE, Cornwall ML, Garcia F, Shulman ST, Rowley AH. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis 2001; 184: 940–943.

  16. Takeshita S, Tokutomi T, Kawase H, Nakatani K, Tsujimoto H, Kawamura Y, Sekine I. Elevated serum levels of matrix metalloproteinase-9 (MMP-9) in Kawasaki disease. Clin Exp Immunol 2001; 125: 340-344.

  17. Yasukawa K, Terai M, Shulman ST, Toyozaki T, Yajima S, Kohno Y, Rowley AH. Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease. Circulation 2002; 105: 766–769.

  18. Asano T, Ogawa S. Expression of monocyte chemoattractant protein-1 in Kawasaki disease: the anti-inflammatory effect of gamma globulin therapy. Scand J Immunol 2000; 51: 98-103.

  19. Eberhard BA, Andersson U, Laxer RM, Rose V, Silverman ED. Evaluation of the cytokine response in Kawasaki disease. Pediatr Infect Dis J 1995; 14: 199-203.

  20. Sundel R, Szer I. Vasculitis in childhood. Rheum Dis Clin North Am 2002; 28: 625.

  21. Burns JC, Wiggins JWJr, Toews WH et al. Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr 1986; 109: 759-763.

  22. Newburger JW, Taubert KA, Shulman ST, et al. Summary and abstracts of the Seventh International Kawasaki Disease Symposium: December 4-7, 2001, Hakone, Japan. Pediatr Res 2003; 53: 153.

  23. Kamiya T, Suzuki A, Ono Y, Arakaki Y, Tsuda E, Fujiwara M et al. Angiographic follow-up study of coronary artery lesion in the cases with a history of Kawasaki disease-with a focus on the follow-up more than ten years after the onset of the disease. In: Kato H, ed. Kawasaki disease. Proceedings of the 5th International Kawasaki Disease Symposium. Fukuoka, Japan, 22–25 May 1995. New York, NY: Elsevier Science; 1995: 569–573.

  24. Yanagihara R, Todd JK. Acute febrile mucocutaneous lymph node syndrome. Am J Dis Child 1980; 134: 603.

  25. Pickering LK, ed. Red Book. Report of the Committee on Infectious Diseases. Chicago, Ill: American Academy of Pediatrics; 2003.




2020     |     www.medigraphic.com